• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Circulating anti-PLA2R autoantibodies to monitor immunological activity in membranous nephropathy.

作者信息

Cravedi Paolo, Ruggenenti Piero, Remuzzi Giuseppe

出版信息

J Am Soc Nephrol. 2011 Aug;22(8):1400-2. doi: 10.1681/ASN.2011060610. Epub 2011 Jul 22.

DOI:10.1681/ASN.2011060610
PMID:21784892
Abstract
摘要

相似文献

1
Circulating anti-PLA2R autoantibodies to monitor immunological activity in membranous nephropathy.循环抗磷脂酶A2受体自身抗体用于监测膜性肾病的免疫活性。
J Am Soc Nephrol. 2011 Aug;22(8):1400-2. doi: 10.1681/ASN.2011060610. Epub 2011 Jul 22.
2
[Anti-phospholipase A2 receptor (anti-PLA2R) antibodies and idiopathic membranous nephropathy: which role in diagnosis and prognosis of this disease?].[抗磷脂酶A2受体（抗PLA2R）抗体与特发性膜性肾病：在该疾病的诊断和预后中起何种作用？]
G Ital Nefrol. 2014 May-Jun;31(3).
3
PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy.膜性肾病中的PLA2R自身抗体和PLA2R肾小球沉积物
N Engl J Med. 2011 Feb 17;364(7):689-90. doi: 10.1056/NEJMc1011678.
4
[Preliminary results of research on a new marker of idiopathic membranous nephropathy: anti-PLA2R].[特发性膜性肾病新标志物抗磷脂酶A2受体的研究初步结果]
Pol Merkur Lekarski. 2014 Mar;36(213):171-4.
5
Immunological remission in PLA2R-antibody-associated membranous nephropathy: cyclophosphamide versus rituximab.磷脂酶A2受体（PLA2R）抗体相关膜性肾病的免疫缓解：环磷酰胺与利妥昔单抗对比
Kidney Int. 2018 Apr;93(4):1016-1017. doi: 10.1016/j.kint.2017.12.019.
6
PLA2R autoantibodies and recurrent membranous nephropathy after transplantation.磷脂酶A2受体自身抗体与移植后复发性膜性肾病
N Engl J Med. 2010 Jul 29;363(5):496-8. doi: 10.1056/NEJMc1003066.
7
Anti-PLA₂R antibodies in membranous nephropathy: ready for routine clinical practice?膜性肾病中的抗磷脂酶A₂受体抗体：准备好用于常规临床实践了吗？
Neth J Med. 2012 Apr;70(3):109-13.
8
Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.肾小球中 M 型磷脂酶 A2 受体的表达增强与原发性膜性肾病患者血清受体抗体相关。
Kidney Int. 2012 Oct;82(7):797-804. doi: 10.1038/ki.2012.209. Epub 2012 Jun 6.
9
Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy.特发性膜性肾病患儿中抗M型磷脂酶A2受体抗体
Nephrology (Carlton). 2015 Aug;20(8):572-5. doi: 10.1111/nep.12478.
10
Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.特发性膜性肾病中循环抗体水平及肾沉积抗M型磷脂酶A2受体的患病率、诊断价值及临床特征
Nefrologia. 2014 May 21;34(3):353-9. doi: 10.3265/Nefrologia.pre2013.Dec.12291. Epub 2014 Feb 10.

引用本文的文献

1
Clinicopathological and prognostic study of idiopathic membranous nephropathy with tip or non-tip variant focal segmental glomerulosclerosis: a single-center cohort study.伴顶端或非顶端变异型局灶节段性肾小球硬化的特发性膜性肾病的临床病理及预后研究：一项单中心队列研究
Ren Fail. 2025 Dec;47(1):2512052. doi: 10.1080/0886022X.2025.2512052. Epub 2025 Jun 8.
2
Diagnostic Usefulness of Antibodies Against M-type Phospholipase A2 Receptor (aPLA2R) in Primary Membranous Nephropathy in the Mexican Population.抗M型磷脂酶A2受体（aPLA2R）抗体在墨西哥人群原发性膜性肾病中的诊断价值
Cureus. 2023 Aug 16;15(8):e43588. doi: 10.7759/cureus.43588. eCollection 2023 Aug.
3
Sexual dimorphic response to rituximab treatment: A longitudinal observational study in a large cohort of patients with primary membranous nephropathy and persistent nephrotic syndrome.
利妥昔单抗治疗的性别差异反应：一项针对大量原发性膜性肾病和持续性肾病综合征患者队列的纵向观察研究。
Front Pharmacol. 2022 Sep 2;13:958136. doi: 10.3389/fphar.2022.958136. eCollection 2022.
4
Lipoic acid supplementation associated with neural epidermal growth factor-like 1 (NELL1)-associated membranous nephropathy.硫辛酸补充与神经表皮生长因子样 1（NELL1）相关的膜性肾病有关。
Kidney Int. 2021 Dec;100(6):1208-1213. doi: 10.1016/j.kint.2021.10.010. Epub 2021 Oct 16.
5
Receptor antibody time-resolved A2 phospholipase bead immunochromatography and its application in idiopathic membranous nephropathy.受体抗体时间分辨 A2 磷脂酶珠免疫层析及其在特发性膜性肾病中的应用。
J Clin Lab Anal. 2020 Dec;34(12):e23508. doi: 10.1002/jcla.23508. Epub 2020 Aug 6.
6
Prognostic value of phospholipase A2 receptor in primary membranous nephropathy: a systematic review and meta-analysis.磷脂酶 A2 受体在原发性膜性肾病中的预后价值：系统评价和荟萃分析。
Int Urol Nephrol. 2019 Sep;51(9):1581-1596. doi: 10.1007/s11255-019-02147-9. Epub 2019 May 28.
7
Changing the concepts of immune-mediated glomerular diseases through proteomics.通过蛋白质组学改变免疫介导性肾小球疾病的观念。
Proteomics Clin Appl. 2015 Dec;9(11-12):967-71. doi: 10.1002/prca.201400159. Epub 2015 Jun 17.
8
Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy.抗磷脂酶A2受体抗体滴度可预测利妥昔单抗治疗后膜性肾病的疗效。
J Am Soc Nephrol. 2015 Oct;26(10):2545-58. doi: 10.1681/ASN.2014070640. Epub 2015 Mar 24.
9
Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: A report from Iranian population.特发性膜性肾病中的抗磷脂酶A2受体抗体：来自伊朗人群的报告。
J Nephropathol. 2013 Oct;2(4):241-8. doi: 10.12860/JNP.2013.38. Epub 2013 Oct 1.
10
The primary glomerulonephritides: a systems biology approach.原发性肾小球肾炎：系统生物学方法。
Nat Rev Nephrol. 2013 Sep;9(9):500-12. doi: 10.1038/nrneph.2013.129. Epub 2013 Jul 16.